daily equity report by epic research of 17 august 2016
TRANSCRIPT
YOUR MINTVISORY Call us at +91-731-6642300
17th AUGUST 2016
DAILY EQUITY REPORT
Our Presence
Epic Research India
411 Milinda Manor (Suites 409- 417)
2 RNT Marg. Opp Central Mall
Indore (M.P.)
Hotline: +91 731 664 2300
Or give us a missed call at
026 5309 0639
HNI & NRI Sales Contact Australia
Mintara Road, Tarneit, Victoria. Post Code 3029
Phone.: +61 422 063855
HNI & NRI Sales Contact USA
2117 Arbor Vista Dr. Charlotte (NC)
Cell: +1 704 249 2315
Toll Free Number
1-800-200-9454
All queries should be directed to
YOUR MINTVISORY Call us at +91-731-6642300
17th AUGUST 2016
DAILY MARKET WRAPUP
INDIAN INDICES
INDEX CMP Change % Chg
NIFTY 8642.55 -29.60 -0.34
SENSEX 28064.61 -87.79 -0.31
SECTORAL INDICES
Index Current % Change Open High Low Prev. Close
CNX AUTO 9,558.60 -0.62 9,622.55 9,622.55 9,496.75 9,618.50
CNX ENERGY 9,445.40 0.12 9,442.65 9,538.60 9,407.90 9,434.50
CNX FINANCE 7,831.95 -0.18 7,862.10 7,867.85 7,769.55 7,846.40
CNX FMCG 22,396.00 -0.01 22,426.00 22,587.40 22,338.45 22,397.40
CNX INFRA 2,918.50 0.49 2,909.85 2,927.10 2,896.95 2,904.35
CNX IT 10,993.55 -1.61 11,121.95 11,136.05 10,955.65 11,173.40
CNX MEDIA 2,814.00 -0.10 2,797.35 2,820.10 2,790.30 2,816.85
CNX METAL 2,550.10 1.59 2,514.95 2,556.05 2,503.85 2,510.15
CNX MNC 10,217.75 -0.46 10,292.50 10,302.15 10,181.55 10,265.35
NI15 5,532.85 -0.67 5,564.05 5,580.05 5,519.55 5,570.40
CNX PHARMA 11,420.00 0.51 11,418.35 11,433.20 11,320.30 11,362.40
CNX PSE 3,462.70 0.68 3,442.20 3,480.45 3,442.20 3,439.30
CNX PSU BANK 2,984.40 0.80 2,980.90 3,002.20 2,943.70 2,960.70
CNX REALTY 207.65 -0.67 208.95 209.20 205.15 209.05
CNX SERVICE 11,030.10 -0.47 11,068.70 11,083.55 10,975.70 11,081.75
YOUR MINTVISORY Call us at +91-731-6642300
17th AUGUST 2016
EPIC RESEARCH– ANALYST SPEAKS
Nifty in yesterday trading session remained volatile between the range of 8600-8700. it opened with slim gains and finally closed almost flat. As global cues are mixed Nifty may also perform the same. So we advise you to buy Nifty from some dip around 8620-8600 for the targets of 8680 and 8750 with strict stop loss of 8500.
NIFTY
RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2
8723.70 8683.00 8641.70 8601.10 8559.80
YOUR MINTVISORY Call us at +91-731-6642300
17th AUGUST 2016
EPIC RESEARCH– ANALYST SPEAKS
BANKNIFTY in yesterday trading session remained volatile, it opened with some gains and came down then later again recovered losses and ended with some gains. It may follow the trend today also as it has a resistance on current levels. So we advise you to buy Banknifty on some dips around 18950 for the targets of 19050 and 19150 with strict stop loss of 18800.
BANKNIFTY
RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2
19190.00 19096.00 18967.00 18873.00 18744.00
YOUR MINTVISORY Call us at +91-731-6642300
17th AUGUST 2016
EPIC RESEARCH– ANALYST SPEAKS
Last trading session BHARATFORGE future shown out-performance in AUTO sector and stock open flattish note but saw good strength in second half and closed near major resistance level with bullish candlestick on daily chart and since last session it rose with rising OI in long side.We may see sharp rise for that it will be good to buy above 844 for the target of 850-860 with SL of 833.
BHARATFORGE FUTURE
YOUR MINTVISORY Call us at +91-731-6642300
17th AUGUST 2016
EPIC RESEARCH– ANALYST SPEAKS
Last session SUNPHARMA Future again shown under pressure during the day. And closd with bearish candlestick on daily chart, while before last session stock made a low of 783 and respect major support level, So if stock break suppoort level, we may seen sharp fall this stock ,we advise to sell below 782 for the target of 776-767 with stop loss of 792.
SUNPHARMA FUTURE
YOUR MINTVISORY Call us at +91-731-6642300
17th AUGUST 2016
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up
on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility.
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of
the information is the acceptance of this disclaimer. All Rights Reserved.
Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer
to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then
Serious Legal Actions can be taken.
DISCLAIMER